|
1) Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA cancer J Clin. 2009; 59: 225-49
|
|
|
|
2) 高山哲治, 岡村誠介, 岡久稔也, 他. Chemopreventionの基礎と臨床. 癌と化学療法. 2008; 35: 1067-71
|
|
|
|
|
3) Burt RW, DiSario JA, Cannon-Albright L, et al. Genetics of colon cancer: impact of inheritance on colon cancer risk. Annu Rev Med. 1995; 46: 371-9
|
|
|
|
|
|
4) Fukata M, Chen A, Vamadevan AS, et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology. 2007; 133: 1869-81
|
|
|
|
|
|
5) Lin S, Wang D, Iyer S, et al. The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer. Gastroenterology. 2009; 136: 1711-20
|
|
|
|
|
|
6) Larsson SC, Orsini N, Wolk A, et al. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005; 97: 1679-87
|
|
|
|
|
|
7) Oh SW, Kim YH, Choi YS, et al. The comparison of the risk factors and clinical manifestations of proximal and distal colorectal cancer. Dis Colon Rectum. 2008; 51: 56-61
|
|
|
|
|
|
8) Potter JD. Colorectal cancer: molecules and populations. J Natl Cancer Inst. 1999; 91: 916-32
|
|
|
|
|
|
9) Chan AO, Jim MH, Lam KF, et al. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. JAMA. 2007; 298: 1412-9
|
|
|
|
|
|
10) Botteri E, Iodice S, Bagnardi V, et al. Smoking and colorectal cancer; A meta-analysis. JAMA. 2008; 300: 2765-78
|
|
|
|
|
|
11) Botteri E, Iodice S, Raimondi S, et al. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology. 2008; 134: 388-95
|
|
|
|
|
|
12) Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007; 297: 2351-9
|
|
|
|
|
|
13) Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus progestin and colorectal cancer postmenopausal women. N Engl J Med. 2004; 350: 991
|
|
|
|
|
|
14) Poynter JN, Gruber SB, Higgins PD, et al. Statins and the risk of colorectal cancer. N Engl J Med. 2005; 352: 2184
|
|
|
|
|
|
15) Bjelakovic G, Nagorni A, Nikolova D, et al. Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma. Aliment Pharmacol Ther. 2006; 24: 281
|
|
|
|
|
|
16) Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005; 294: 47
|
|
|
|
|
|
17) Inafuku Y, Furuhata T, Tayama M, et al. Matrix metalloproteinase-2 expression in stromal tissues is a consistent prognostic factor in stage II colon cancer. Cancer Sci. 2009; 100: 852-8
|
|
|
|
|
|
18) Giovannucci EL, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995; 333: 609
|
|
|
|
|
|
19) Chan AT, Giovannucci EL, Meyerhardt HA, et al. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA. 2005; 294: 914
|
|
|
|
|
|
20) Ajani JA, Curley SA, Janjan NA, et al. 上西紀夫, 監訳. 消化器癌 M. D. Anderson Cancer Care Series. 東京: シュプリンガー・ジャパン; 2007. p. 45-73
|
|
|
|
|
|
21) Gerner EW, Meyskens FL. Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation. Clin Cancer Res. 2009; 15: 758-61
|
|
|
|
|
|
22) Fields AP, Calcagno SR, Krishna M, et al. Protein kinase Cβ is an effective target for chemoprevention of colon cancer. Cancer Res. 2009; 69: 1643-50
|
|
|
|
|